
Lithium vs. Quetiapine: Augmenting Treatment-Resistant Depression
Psychopharmacology and Psychiatry Updates
00:00
Risk-Benefit Considerations in Augmentation
Paul Zarkowski argues that both medications have concerning profiles and should be justified especially in bipolar depression.
Play episode from 08:40
Transcript


